Literature DB >> 15748539

Molecular evidence of tissue renin-angiotensin systems: a focus on the brain.

Koji Sakai1, Curt D Sigmund.   

Abstract

Hypertension remains one of the largest human health problems, because hypertensive patients carry increased risk for ischemic heart disease, stroke, atherosclerosis, and renal failure. The renin-angiotensin system (RAS) has been intensively investigated for more than 100 years because it is a powerful regulator of blood pressure, and the antihypertensive benefits of RAS inhibitors are very clear. Despite a wealth of clinical and basic studies, the precise mechanisms by which the RAS regulates blood pressure remains incomplete. In this chapter, we review data demonstrating the existence and function of intrinsic tissue RAS, with a primary focus on the brain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15748539      PMCID: PMC7088661          DOI: 10.1007/s11906-005-0088-y

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  60 in total

1.  An alternative transcript of the rat renin gene can result in a truncated prorenin that is transported into adrenal mitochondria.

Authors:  S Clausmeyer; R Stürzebecher; J Peters
Journal:  Circ Res       Date:  1999-02-19       Impact factor: 17.367

2.  Angiotensin II receptor subtype distribution in the rabbit brain.

Authors:  Sabyasachi Moulik; Robert C Speth; Barbara B Turner; Brian P Rowe
Journal:  Exp Brain Res       Date:  2001-11-30       Impact factor: 1.972

3.  Localization of renin expressing cells in the brain, by use of a REN-eGFP transgenic model.

Authors:  Julie L Lavoie; Martin D Cassell; Kenneth W Gross; Curt D Sigmund
Journal:  Physiol Genomics       Date:  2004-01-15       Impact factor: 3.107

4.  Brain-selective overexpression of angiotensin (AT1) receptors causes enhanced cardiovascular sensitivity in transgenic mice.

Authors:  Eric Lazartigues; Shannon M Dunlay; Angela K Loihl; Puspha Sinnayah; Julie A Lang; Joshua J Espelund; Curt D Sigmund; Robin L Davisson
Journal:  Circ Res       Date:  2002-03-22       Impact factor: 17.367

5.  Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen.

Authors:  M Schinke; O Baltatu; M Böhm; J Peters; W Rascher; G Bricca; A Lippoldt; D Ganten; M Bader
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

6.  Angiotensin converting enzyme in the human basal forebrain and midbrain visualized by in vitro autoradiography.

Authors:  S Y Chai; J S McKenzie; M J McKinley; F A Mendelsohn
Journal:  J Comp Neurol       Date:  1990-01-08       Impact factor: 3.215

7.  Delayed maturation of catecholamine phenotype in nucleus tractus solitarius of rats with glial angiotensinogen depletion.

Authors:  Michael Ogier; Laurent Bezin; Jean-Marie Cottet-Emard; Michael Bader; Madeleine Vincent; Jean-Marc Pequignot; John McGregor; Giampiero Bricca
Journal:  Hypertension       Date:  2003-09-29       Impact factor: 10.190

8.  Brain-specific restoration of angiotensin II corrects renal defects seen in angiotensinogen-deficient mice.

Authors:  Nadheige Lochard; David W Silversides; Jorge P van Kats; Chantal Mercure; Timothy L Reudelhuber
Journal:  J Biol Chem       Date:  2002-10-23       Impact factor: 5.157

9.  Astrocytes synthesize angiotensinogen in brain.

Authors:  R L Stornetta; C L Hawelu-Johnson; P G Guyenet; K R Lynch
Journal:  Science       Date:  1988-12-09       Impact factor: 47.728

Review 10.  Novel angiotensin peptides.

Authors:  C M Ferrario; M C Chappell
Journal:  Cell Mol Life Sci       Date:  2004-11       Impact factor: 9.261

View more
  15 in total

Review 1.  Lessons from in vitro studies and a related intracellular angiotensin II transgenic mouse model.

Authors:  Julia L Cook; Richard N Re
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

2.  Functional intracellular renin-angiotensin systems: potential for pathophysiology of disease.

Authors:  Robert M Carey
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

Review 3.  Muscle mechanoreflex overactivity in hypertension: a role for centrally-derived nitric oxide.

Authors:  Scott A Smith; Anna K Leal; Megan N Murphy; Ryan M Downey; Masaki Mizuno
Journal:  Auton Neurosci       Date:  2015-01-02       Impact factor: 3.145

4.  Obesity-associated extracellular mtDNA activates central TGFβ pathway to cause blood pressure increase.

Authors:  Albert Alé; Yalin Zhang; Cheng Han; Dongsheng Cai
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-11-15       Impact factor: 4.310

Review 5.  Reactive oxygen species in the neuropathogenesis of hypertension.

Authors:  Jeffrey R Peterson; Ram V Sharma; Robin L Davisson
Journal:  Curr Hypertens Rep       Date:  2006-06       Impact factor: 5.369

Review 6.  Hypothalamic inflammation: a double-edged sword to nutritional diseases.

Authors:  Dongsheng Cai; Tiewen Liu
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

Review 7.  Update on tissue renin-angiotensin systems.

Authors:  Michael Bader; Detlev Ganten
Journal:  J Mol Med (Berl)       Date:  2008-04-15       Impact factor: 4.599

8.  Preservation of intracellular renin expression is insufficient to compensate for genetic loss of secreted renin.

Authors:  Di Xu; Giulianna R Borges; Justin L Grobe; Christopher J Pelham; Baoli Yang; Curt D Sigmund
Journal:  Hypertension       Date:  2009-10-12       Impact factor: 10.190

9.  Characterization of a functional (pro)renin receptor in rat brain neurons.

Authors:  Zhiying Shan; Adolfo E Cuadra; Colin Sumners; Mohan K Raizada
Journal:  Exp Physiol       Date:  2008-03-07       Impact factor: 2.969

10.  Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension.

Authors:  Srinivas Sriramula; Jeffrey P Cardinale; Joseph Francis
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.